Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.04 AUD
Change Today -0.002 / -4.76%
Volume 1.0M
TIS On Other Exchanges
As of 9:23 PM 10/4/15 All times are local (Market data is delayed by at least 15 minutes).

tissue therapies ltd (TIS) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/19/15 - A$0.37
52 Week Low
06/11/15 - A$0.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TISSUE THERAPIES LTD (TIS)

Related News

No related news articles were found.

tissue therapies ltd (TIS) Related Businessweek News

No Related Businessweek News Found

tissue therapies ltd (TIS) Details

Tissue Therapies Limited, a biomedical technology company, researches, develops, and commercializes biomedical heating technologies for chronic wound healing and tissue regeneration worldwide. It offers VitroGro ECM, a synthetic matrix protein comprising a portion of vitronectin and IGF-1. The company develops treatments for acute and chronic wound healing applications, such as chronic skin ulcers and burns. Tissue Therapies Limited is headquartered in Brisbane, Australia.

tissue therapies ltd (TIS) Top Compensated Officers

Acting Chief Executive Officer and Operations...
Total Annual Compensation: A$46.7K
Compensation as of Fiscal Year 2015.

tissue therapies ltd (TIS) Key Developments

Tissue Therapies Limited Announces Resignation of Iain Ross as Non-Executive Director

The board of directors of Tissue Therapies Limited announced that non-executive Director, Iain Ross resigned with immediate effect.

Tissue Therapies Ltd. Announces Audited Consolidated and Parent Earnings Results for the Year Ended June 30, 2015

Tissue Therapies Ltd. announced audited consolidated and parent earnings results for the year ended June 30, 2015. For the year, on consolidated basis, the company reported continuing operations of AUD 526,177 compared to AUD 746,905 a year ago. Loss before income tax was AUD 11,205,885 compared to AUD 6,815,792 a year ago. Net loss from continuing operations was AUD 11,218,514 compared to AUD 6,829,591 a year ago. Net loss attributable to members of the company was AUD 11,216,514 compared to AUD 6,829,591 a year ago. Basic and diluted loss per share was 4.03 cents compared to 2.82 cents a year ago. Net cash used in operating activities was AUD 9,044,960 compared to AUD 7,074,363 a year ago. Payments for property, plant and equipment was AUD 5,442 compared to AUD 17,289 a year ago. For the year, on parent basis, total losses were AUD 11,269,591 compared to AUD 6,881,440 a year ago.

Tissue Therapies Announces Executive Changes

Tissue Therapies announced the appointment Ms. Saskia Jo as Company Secretary. Ms. Jo is a CPA and Chartered Secretaries of Australia member, and previously spent more than three years as Tissue Therapies’ Corporate Accountant. Ms. Jo replaces Mr. Drummond McKenzie who served as Tissue Therapies’ Company Secretary from 2003 to 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TIS:AU A$0.04 AUD -0.002

TIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TIS.
View Industry Companies

Industry Analysis


Industry Average

Valuation TIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 31.7x
Price/Book 0.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 17.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TISSUE THERAPIES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at